Kiran A. Kumar, MD, MBA

365 posts

Kiran A. Kumar, MD, MBA banner
Kiran A. Kumar, MD, MBA

Kiran A. Kumar, MD, MBA

@kakumar86

Rad Onc @UTSW_RadOnc | Lymph/Peds/Sarc | Residency PD #MedEd | @StanfordRadOnc @BerkeleyHaas @UChicagoMed @UArizona Alum | AZ Sports Fan | Mixologist. Views=me

Dallas, TX Katılım Nisan 2017
930 Takip Edilen1.2K Takipçiler
Kiran A. Kumar, MD, MBA
Kiran A. Kumar, MD, MBA@kakumar86·
@StanfordRadOnc Congrats Rich! Can’t think of a bigger role model- responsible for me choosing academics and lymphoma specifically, 7.5 years into being an attending and still always think WWRD for any challenging case 😜 Enjoy a very happy, healthy, and meaningful retired life! 🥂
English
0
0
3
199
Stanford Radiation Oncology
Stanford Radiation Oncology@StanfordRadOnc·
Please join us in congratulating Dr. Richard Hoppe, MD, on beginning his next chapter: retirement! Thank you for your leadership, your wisdom, and your friendship. Wishing you a retirement filled with as much joy and discovery as you brought to our department every day!
Stanford Radiation Oncology tweet media
English
2
3
39
1.4K
Dr. Nina Niu Sanford
Dr. Nina Niu Sanford@NiuSanford·
Back for round 2 @ASCO LDP! Enjoying these sessions. 3 days to recharge, reflect, & connect with great peers/mentors (Plus we are well fed!)
Dr. Nina Niu Sanford tweet media
English
1
5
44
3.2K
Kiran A. Kumar, MD, MBA
Kiran A. Kumar, MD, MBA@kakumar86·
My first clinical trial! While was just short of our hypothesis that early salvage ISRT after CAR-T can double CR rate from d30 to d90 PET, interesting subset and translative analyses forthcoming for when this could be great salvage option post-CAR-T (e.g. single site of PR)…
UTSW Radiation Oncology@UTSW_RadOnc

During a session on clinical trials shaping the future of RT, Dr. @kakumar86 presented his work, “Phase II Trial of ‘Re-Priming’ Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after CAR-T Therapy.” #ASTRO25

English
2
7
48
5.9K
Kiran A. Kumar, MD, MBA
Kiran A. Kumar, MD, MBA@kakumar86·
I swear there were people there (just empty front row)! Happy to have presented our pos phase II clinical trial results from PROMISE, which has revolutionized our ability to safely (with built in gating as safety mech) treat young children (3-7) without sedation! #ASTRO25
UTSW Radiation Oncology@UTSW_RadOnc

To close out a day of fantastic research, our Chief of Peds and Lymphoma Radiation Oncology Services, Dr. @kakumar86 presented his work during the Best of Physics session about the PROMISE clinical trial to reduce anesthesia use in pediatric patients undergoing RT. #ASTRO25

English
2
3
33
4.9K
Kiran A. Kumar, MD, MBA retweetledi
UTSW Radiation Oncology
UTSW Radiation Oncology@UTSW_RadOnc·
Do you have an interest in radiation oncology? Join our Virtual Meet and Greet next Wednesday! You'll have the opportunity talk with some of our faculty and medical residents about our medical residency program! Zoom link🔗: bit.ly/46bdKQU
UTSW Radiation Oncology tweet media
English
1
4
11
1.1K
Kiran A. Kumar, MD, MBA retweetledi
UTSW Radiation Oncology
UTSW Radiation Oncology@UTSW_RadOnc·
Join us for the second PULSAR Consortium Meeting at @ASTRO_org on Monday, September 29, at 6 p.m! This special meeting will feature in-depth discussions with leading experts on PULSAR in clinical practice. Register and learn more in the link below. 🔗: bit.ly/3Vng68X
UTSW Radiation Oncology tweet media
English
1
13
22
2.6K
Brandon M. Godinich-Mitchell MBA, MHA
Brandon M. Godinich-Mitchell MBA, MHA@BMGodinich·
Grateful for 4 weeks at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern in Radiation Oncology. Learned from incredible faculty & residents and presented on advances in radiation de-escalation for breast cancer.
Brandon M. Godinich-Mitchell MBA, MHA tweet mediaBrandon M. Godinich-Mitchell MBA, MHA tweet media
English
3
2
11
1.2K
Kiran A. Kumar, MD, MBA
Kiran A. Kumar, MD, MBA@kakumar86·
@HenningWillers Congrats Dr. Gibbs and all! Dr. Gibbs was/is one of the most influential mentors in my life and couldn’t think of someone more deserving
English
0
0
2
91
Henning Willers, MD, FASTRO
Henning Willers, MD, FASTRO@HenningWillers·
Congratulation to all awardees🎉🥳, especially our own Helen Shih who we are so lucky to have amongst us. Dr Shih's passion for mentoring and excellence is absolutely amazing, and she does it all with the highest level of diligence & integrity. An inspiration to all of us‼️ 👏👏👏 @MGHCancerCenter @MGH_WiO @BrighamRadOnc @DKirschMDPhD @AmyWisdom8 @RachelJimenezMD @AE_MarciscanoMD @EmilyLebow
ASTRO@ASTRO_org

Congratulations to Iris Gibbs, MD, FASTRO; Helen Shih, MD, MS, MPH, FASTRO; & Joachim Yahalom, MD, FASTRO on their 2025 ASTRO Mentorship awards!! They will be recognized at #ASTRO25 in San Francisco. @StanfordRadOnc @MassGeneralNews @MSK_RadOnc ow.ly/A1cB50WlXIa

English
5
6
43
3.4K
Kiran A. Kumar, MD, MBA
Kiran A. Kumar, MD, MBA@kakumar86·
Innovative educator by day, HH bff by night 👩🏻‍🏫 🍸 Another great video for residents/students/all, make sure to check out! 💯
Kiran A. Kumar, MD, MBA tweet media
Dr. Nina Niu Sanford@NiuSanford

GI Pathology 101! For each subsite, we go through path basics – histology, IHC & molecular markers, key features from resection specimen & more. I ask @SuntreaHammer to explain path slides to me like I’m a 5-year-old 😀 Here's Part 1: CRC Full video link & slides below🧵1/4:

English
1
1
20
3.2K
Kiran A. Kumar, MD, MBA retweetledi
UTSW Radiation Oncology
UTSW Radiation Oncology@UTSW_RadOnc·
Congratulations to graduating medical resident Dr. @MihailoMiljanic, who received the David A. Pistenmaa Award!
UTSW Radiation Oncology tweet media
English
1
2
18
837
Kiran A. Kumar, MD, MBA retweetledi
UTSW Radiation Oncology
UTSW Radiation Oncology@UTSW_RadOnc·
As you take the next step in your careers, we celebrate the incredible journey of our graduating medical residents! Your commitment to excellence and patient care has been truly inspiring. Congratulations and best wishes for what lies ahead!
UTSW Radiation Oncology tweet mediaUTSW Radiation Oncology tweet mediaUTSW Radiation Oncology tweet mediaUTSW Radiation Oncology tweet media
English
1
4
29
4.7K
Kiran A. Kumar, MD, MBA
Kiran A. Kumar, MD, MBA@kakumar86·
Congrats to our rising PGY-4 Brett Tortelli for being named one of the four 2025 ARRO-ASTRO Global Health Scholars 👏🏾 He has an awesome global health research year planned and this is just one of many awards/grants he’s received 💯 @UTSW_RadOnc
ARRO@ARRO_org

Announcing the 2025 ARRO-ASTRO Global Health Scholars! CONGRATULATIONS! Dr. Bethel Adefres – Yale New Haven Hospital Dr. Kara Banson – NYU Langone Health Dr. Kelly Becht – Yale School of Medicine Dr. Brett Tortelli – UT Southwestern Medical Center

English
0
2
23
2.3K
Kiran A. Kumar, MD, MBA retweetledi
Mona Arbab, MD MEd
Mona Arbab, MD MEd@MonaArbabMD·
Congratulations to our PGY3, Dr. Brett Tortelli! We can’t wait to see all the amazing research you will continue to do. @UTSW_RadOnc
ARRO@ARRO_org

Announcing the 2025 ARRO-ASTRO Global Health Scholars! CONGRATULATIONS! Dr. Bethel Adefres – Yale New Haven Hospital Dr. Kara Banson – NYU Langone Health Dr. Kelly Becht – Yale School of Medicine Dr. Brett Tortelli – UT Southwestern Medical Center

English
0
3
11
1.3K
Kiran A. Kumar, MD, MBA retweetledi
Dr. Nina Niu Sanford
Dr. Nina Niu Sanford@NiuSanford·
Congrats to our 5 graduating residents: Drs. Maureen Aliru, Ahmed Elamir, Meng-Lun Hsieh, Misha Miljanic, & Steven Montalvo. Great doctors & even better people! (Graduation was early this year, meaning we get another month w these awesome seniors). Gonna miss them so much ❤️
Dr. Nina Niu Sanford tweet mediaDr. Nina Niu Sanford tweet mediaDr. Nina Niu Sanford tweet mediaDr. Nina Niu Sanford tweet media
English
3
7
60
4.4K
Kiran A. Kumar, MD, MBA
Kiran A. Kumar, MD, MBA@kakumar86·
Congrats to our two stellar @UTSW_RadOnc med students Katherine and Ethan on graduating today! Really proud of them for their successes and happy to see the tradition of matching @HarvardRadOnc continuing 🥹🥂🥳
Kiran A. Kumar, MD, MBA tweet mediaKiran A. Kumar, MD, MBA tweet media
English
2
3
45
6.5K
Kiran A. Kumar, MD, MBA
Kiran A. Kumar, MD, MBA@kakumar86·
@PhilBlumenfeld Can completely relate- when we started had same issues, breath hold helped a lot, and then hyper sight was a game changer; with both we have no reason to use out MR-linac for gastric MALT as image quality is great and oART process is much faster (stomach changes in tens of mins)
English
0
0
2
83
Phil Blumenfeld
Phil Blumenfeld@PhilBlumenfeld·
@kakumar86 Excellent! We had issues with CBCT quality (ethos, no hyper sight) for upper abdomen (Gastric MALT). I hope with hyper sight (eventually) we can offer again this treatment for our patients.
English
1
0
3
193
Kiran A. Kumar, MD, MBA
Kiran A. Kumar, MD, MBA@kakumar86·
Would argue that lymphomas are one of the most important diseases to consider adaptive RT as they are exquisitely radiosensitive, often in difficult to target locations, and many have long term survival so even small decreases in dose to OARs are likely meaningful. Excited… 1/2
ASTRO@ASTRO_org

Adaptive RT in lymphomas ➡️ better targeting w/ reduced margins, deceased dose to OARs, adaptation to shrinking tumors, shorter course treatments, & easier treatments of multi-targets/SIBs. Read @kakumar86 @UTSW_RadOnc et al's article in the #RedJournal: tinyurl.com/kumarrj

English
4
9
49
5.9K

Keşfet

@StanfordRadOnc @NiuSanford @ASCO @montypal @DVAraujoMD @atlal_abusanad @umangtalking @ndesai2005